Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Soelberg Sørensen

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Journal of the Neurological Sciences|December 31, 2011
Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosisPer Soelberg Sørensen
Nature Reviews. Neurology|December 5, 2015
Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?Per Soelberg Sørensen
Ugeskrift for Laeger|June 21, 2008
[Biological treatment of multiple sclerosis]Per Soelberg Sørensen, Finn Sellebjerg
CNS Drugs|March 13, 2017
Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage AgentsMorten Blinkenberg, Per Soelberg Sørensen
Ugeskrift for Laeger|March 30, 2012
[Diagnosis of multiple sclerosis--the 2010 revision of the McDonald criteria]Henrik Kahr Mathiesen, Per Soelberg Sørensen
The Lancet. Neurology|April 20, 2010
The changing demographic pattern of multiple sclerosis epidemiologyNils Koch-Henriksen, Per Soelberg Sørensen
Ugeskrift for Laeger|October 28, 2014
[Fampridine and multiple sclerosis]Henrik Kahr Mathiesen, Per Soelberg Sørensen
Ugeskrift for Laeger|May 14, 2013
[Limited effect of interferon-beta for the treatment of secondary progressive multiple sclerosis]Karen Schreiber, Ana Voldsgaard, Per Soelberg Sørensen
European Journal of Neurology|February 21, 2024
Early history of the European Journal of Neurology. A mirror of the evolution of Europe after 1989François Boller, Anne Petrov, Per Soelberg Sørensen
Lancet (London, England)|November 28, 2016
Evolving concepts in the treatment of relapsing multiple sclerosisGiancarlo Comi, Marta Radaelli, Per Soelberg Sørensen
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Journal of the Neurological Sciences|December 31, 2011
Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosisPer Soelberg Sørensen
Nature Reviews. Neurology|December 5, 2015
Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?Per Soelberg Sørensen
Ugeskrift for Laeger|June 21, 2008
[Biological treatment of multiple sclerosis]Per Soelberg Sørensen, Finn Sellebjerg
CNS Drugs|March 13, 2017
Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage AgentsMorten Blinkenberg, Per Soelberg Sørensen
Ugeskrift for Laeger|March 30, 2012
[Diagnosis of multiple sclerosis--the 2010 revision of the McDonald criteria]Henrik Kahr Mathiesen, Per Soelberg Sørensen
The Lancet. Neurology|April 20, 2010
The changing demographic pattern of multiple sclerosis epidemiologyNils Koch-Henriksen, Per Soelberg Sørensen
Ugeskrift for Laeger|October 28, 2014
[Fampridine and multiple sclerosis]Henrik Kahr Mathiesen, Per Soelberg Sørensen
Ugeskrift for Laeger|May 14, 2013
[Limited effect of interferon-beta for the treatment of secondary progressive multiple sclerosis]Karen Schreiber, Ana Voldsgaard, Per Soelberg Sørensen
European Journal of Neurology|February 21, 2024
Early history of the European Journal of Neurology. A mirror of the evolution of Europe after 1989François Boller, Anne Petrov, Per Soelberg Sørensen
Lancet (London, England)|November 28, 2016
Evolving concepts in the treatment of relapsing multiple sclerosisGiancarlo Comi, Marta Radaelli, Per Soelberg Sørensen
Pageof 11